SAN DIEGO, Dec. 7 /PRNewswire-FirstCall/ -- Genoptix, Inc. , a provider of personalized diagnostic services, announced today at the ASH Meeting in Atlanta, Georgia, that it will launch testing for the MPL W515 L/K mutation.